The Vanderbilt-Ingram Cancer Center will present “The Future of Lung Cancer Care,” a one-day educational conference scheduled for May 8, 2024, from 8:30 a.m. to 2:30 p.m. The event will take place at the Nashville Marriott at Vanderbilt University and will address significant advancements in lung cancer treatment and patient care.
The conference aims to highlight recent improvements in patient outcomes and survival rates due to early detection, advanced imaging techniques, minimally invasive procedures, and breakthroughs in targeted and immune-based therapies. According to the State of Lung Cancer report released by the American Lung Association, these advancements have contributed to nearly doubling the five-year survival rate for lung cancer over the past decade.
Expert Insights and Discussions
Attendees will have the opportunity to hear from a range of nationally and internationally recognized experts in the field. Daniel Sterman, MD, director of the Multidisciplinary Pulmonary Oncology Program at New York University Langone Health, will deliver a presentation titled “Interventional Pulmonology: Bronchoscopically Delivered Treatment of Early Lung Cancer.” His insights into innovative treatment methods are expected to provide valuable perspectives for healthcare professionals.
Additionally, Mohamed Shanshal, MBChB, assistant professor of Medicine in the Division of Hematology and Oncology at Vanderbilt Health, will speak on “Medical Oncology: Integrating Immunotherapy, Targeted Therapy, and Beyond.” His session will delve into the evolving landscape of medical oncology, emphasizing the integration of new therapies into patient care.
Another key speaker, Joseph Mammarappallil, MD, PhD, associate professor of Radiology and cardiothoracic imaging specialist at Duke University School of Medicine, will discuss “Interventional Radiology: Imaging-Driven Precision and Local Control.” His expertise will shed light on the role of imaging in enhancing precision in lung cancer treatment.
Topics and Audience Engagement
The conference will cover a wide range of topics, including advances in early detection and diagnostic precision, breakthroughs in minimally invasive biopsy and surgical techniques, and the expanding role of targeted therapy and immunotherapy. Additionally, discussions will address evolving approaches to survivorship and supportive care, further enriching the dialogue surrounding lung cancer treatment.
The event welcomes families, caregivers, clinicians, trainees, and anyone interested in lung cancer care. Physicians attending the conference will be eligible to claim 7.0 AMA PRA Category 1 credits towards their continuing medical education.
Reservations for the conference can be made through Eventbrite, making it accessible for those wishing to participate in this pivotal gathering aimed at improving lung cancer care and outcomes.
